PROTECTIVE EFFECTS OF ANGIOTENSIN II BLOCKADE WITH OLMESARTAN MEDOXOMIL ON RESISTANCE VESSEL REMODELING
The VIOS (Vascular Improvement with Olmesartan medoxomil Study) study is a randomized, parallel study to determine the relative effects of suppressing the renin-angiotensin system (RAS) with the angiotensin receptor antagonist olmesartan medoxomil versus suppressing sympathetic drive with the beta-a...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2010-10-01
|
| Series: | Российский кардиологический журнал |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1500 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|